Epoprostenol therapy as a bridge to pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension.

Editorial. Comments on an article regarding epoprostenol therapy as a bridge to pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension (CTEPH), published in the February 2003 issue of 'Chest.' Management of CTEPH patients requiring a skilled multidisciplinary team consisting of physicians to participate in preoperative assessment and postoperative care.